Hubei Biocause Pharmaceutical000627 
$0.41-6.19%24h
-6.19%24h
Global rank5173
Market cap$2.01B
Change 7d30.91%
YTD Performance1.05%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield9.5%
Hubei Biocause Pharmaceutical (000627) Stock Price History
As for today 000627 price is $0.41, a decrease of -6.19% from yesterday.
The highest price of Hubei Biocause Pharmaceutical is $2.44 on 2015-06-01. It's also known as the all time high (ATH) which refers to the highest price ever reached by a stock in its trading history.
The lowest price of Hubei Biocause Pharmaceutical is $0.09 on 2005-07-01. It's also known as the all time low (ATL) which refers to the lowest price ever reached by a stock in its trading history.
Stock Price History of Hubei Biocause Pharmaceutical from to 2024.
-
Value:-
Stock price history for Hubei Biocause Pharmaceutical by end of year
| Year | Price | Change |
|---|---|---|
| 2024 | $0.3714322030307738 | -7.39% |
| 2023 | $0.4010902876834211 | -10.13% |
| 2022 | $0.4462835595350742 | -4.53% |
| 2021 | $0.4674679057155366 | -32.03% |
| 2020 | $0.6877851059923454 | -30.82% |
| 2019 | $0.9942519807363679 | 25.49% |
| 2018 | $0.7922945471492931 | -29.88% |
| 2017 | $1.13 | 4.58% |
| 2016 | $1.08 | -28.90% |
| 2015 | $1.52 | 162.44% |
| 2014 | $0.579038795599305 | 56.49% |
| 2013 | $0.3700199132854096 | -6.76% |
| 2012 | $0.39685341844732863 | -1.40% |
| 2011 | $0.4025025774287853 | -43.11% |
| 2010 | $0.7075571624274436 | 24.24% |
| 2009 | $0.5694959537898795 | 129.54% |
| 2008 | $0.248105413306594 | -70.98% |
| 2007 | $0.8550072732921886 | 279.66% |
| 2006 | $0.2252023105060234 | 56.91% |
| 2005 | $0.14351970850339654 | -15.01% |
| 2004 | $0.16887313401217394 | -12.84% |
| 2003 | $0.1937421441382914 | -67.12% |
| 2002 | $0.5893216772353016 | -15.39% |
| 2001 | $0.6965144689084412 | 16.09% |
| 2000 | $0.6000028245794907 | 92.20% |
| 1999 | $0.31217958676402047 | 145.09% |
| 1998 | $0.12737582442413886 | -25.83% |
| 1997 | $0.17174149448500856 | -5.71% |
| 1996 | $0.18215006990834237 | - |
Price of Hubei Biocause Pharmaceutical compared to S&P500 (SPY/US500)
Hubei Biocause Pharmaceutical currently underperform the market.
View the most expensive stocks in the world.
